MIGDAL HAEMEK, Israel - April 11, 2018 - TowerJazz (NASDAQ/ TASE: TSEM), the global specialty foundry leader, will issue its first quarter 2018 earnings release on Monday, May 7, 2018. The Company will hold a conference call to discuss its first quarter 2018 financial results and second quarter 2018 guidance on Monday, May 7, 2018, at 10:00 a.m. Eastern Time (09:00 a.m. Central, 08:00 a.m. Mountain, 07:00 a.m. Pacific and 05:00 p.m. Israel time).
This call will be webcasted and can be accessed through the Investor Relations section on TowerJazz's website at http://ir.towerjazz.com/ or by calling the following numbers: U.S. Toll Free: 1-888-668-9141 | Israel: 03-918-0609 | International: +972-3-918-0609.
The teleconference will be available for replay for 90 days.
About TowerJazz
Tower Semiconductor Ltd. (NASDAQ: TSEM, TASE: TSEM) and its subsidiaries operate collectively under the brand name TowerJazz, the global specialty foundry leader. TowerJazz manufactures next-generation integrated circuits (ICs) in growing markets such as consumer, industrial, automotive, medical and aerospace and defense. TowerJazz's advanced technology is comprised of a broad range of customizable process platforms such as: SiGe, BiCMOS, mixed-signal/CMOS, RF CMOS, CMOS image sensor, integrated power management (BCD and 700V), and MEMS. TowerJazz also provides world-class design enablement for a quick and accurate design cycle as well as Transfer Optimization and development Process Services (TOPS) to IDMs and fabless companies that need to expand capacity. To provide multi-fab sourcing and extended capacity for its customers, TowerJazz operates two manufacturing facilities in Israel (150mm and 200mm), two in the U.S. (200mm) and three facilities in Japan (two 200mm and one 300mm). For more information, please visit www.towerjazz.com.
Contact Information:
| TowerJazz Investor Relations | GK Investor Relations |
| Noit Levi, +972 4 604 7066 | Tel: 1 646 201 9246 (US) / +972 8 926 7464 (Israel) |
| [email protected] | [email protected] |
Attachment


Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
FTC Questions Apple News Over Alleged Bias Against Conservative Media
How Marco Pharma International Preserves German Homeopathic Traditions in America
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 



